| 1 |
28744152 | Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. | 2017 |
1 |
| 2 |
28790021 | Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs. | 2017 Oct 11 |
1 |
| 3 |
23963056 | The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol. | 2013 Oct |
2 |
| 4 |
22081145 | Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients. | 2012 Apr |
3 |
| 5 |
19203411 | Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. | 2009 Aug |
2 |
| 6 |
18330213 | Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals. | 2007 |
1 |
| 7 |
10731037 | Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. | 2000 Mar |
2 |
| 8 |
10494878 | Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. | 1999 Aug |
2 |